Senior insider sale
UNITED THERAPEUTICS CORP — senior position signals high conviction
$77.3K
325.00 shares
What this filing means
MESA NILDA plans to sell 325.00 shares of UNITED THERAPEUTICS CORP valued at approximately $77.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/27/2024ACC: 0001950047-24-002714
325.00
Shares to sell
$77.3K
Approx. market value
325.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock
Not Applicable
7/8/2022
92.00Restricted Stock
Not Applicable
6/29/2020
233.00Total acquired325.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/8/2022 | Restricted Stock Not Applicable | 92.00 | — |
6/29/2020 | Restricted Stock Not Applicable | 233.00 | — |
| Total | 325.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
325.00
Market value
$77.3K
3/27/2024
Total
Units
325.00
Value
$77.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/27/2024 | 325.00 | $77.3K | NASDAQ | Planned |
| Total | 325.00 | $77.3K | ||